SECOND REPORTED KINDRED WITH HEREDITARY RESISTANCE TO ORAL ANTICOAGULANT DRUGS

被引:81
作者
OREILLY, RA
机构
关键词
D O I
10.1056/NEJM197006252822602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1448 / &
相关论文
共 18 条
[1]   POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE [J].
AGGELER, PM ;
OREILLY, RA ;
LEONG, L ;
KOWITZ, PE .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) :496-&
[2]   PHYSIOLOGICAL BASIS FOR TRANSFUSION THERAPY IN HEMORRHAGIC DISORDERS - A CRITICAL REVIEW [J].
AGGELER, PM .
TRANSFUSION, 1961, 1 (02) :71-+
[3]  
AGGELER PM, 1969, J LAB CLIN MED, V74, P229
[4]  
AGGELER PM, 1966, THROMB DIATH HAEMO, P227
[5]  
AXELROD J, 1949, P SOC EXP BIOL MED, V70, P693, DOI 10.3181/00379727-70-17036
[6]  
GRAHAM JB, 1959, AM J HUM GENET, V11, P311
[7]   WARFARIN METABOLISM AND VITAMIN K REQUIREMENT IN WARFARIN-RESISTANT RAT [J].
HERMODSON, MA ;
SUTTIE, JW ;
LINK, KP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1969, 217 (05) :1316-+
[9]  
OREILLY RA, 1965, FED PROC, V24, P1266
[10]  
OREILLY RA, 1970, PHARMACOL REV, V22, P35